Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

What do journalists say about covering science during the COVID-19 pandemic?

The pandemic has thrust many mainstream journalists into unfamiliar grounds, including coverage of expert opinion that is not backed up by peer-reviewed content, reporting on preprints, and assessing high-complexity instant-response science. How did they manage? We asked five journalists from mainstream media about their experience.

Apoorva Mandavilli is a reporter on science and global health for The New York Times, USA. Chloé Hecketsweiler covers health, pharmacy and biotechnology for Le Monde, France. Rema Nagarajan is a journalist writing about public health for the Times of India, India. Sabine Righetti writes about science and innovation for Folha de S. Paulo, Brazil. Tamar Khan is a science and health journalist with Business Day, South Africa.

Author information



Corresponding author

Correspondence to Anita Makri.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Makri, A. What do journalists say about covering science during the COVID-19 pandemic?. Nat Med 27, 17–20 (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing